Sequent Scientific
Sequent Scientific Ltd., headquartered in India, is a prominent player in the pharmaceutical and biotechnology sectors. Founded in 2006, the company has established itself as a leader in the development and manufacturing of complex generics, particularly in the areas of injectable and oral dosage forms. With a strong operational presence across various regions, Sequent Scientific has achieved significant milestones, including multiple regulatory approvals from global health authorities. The company’s core offerings include a diverse range of pharmaceutical products, with a unique focus on high-quality, cost-effective solutions that cater to the evolving needs of healthcare providers. Sequent Scientific is recognised for its commitment to innovation and quality, positioning itself as a trusted partner in the global pharmaceutical landscape. Its notable achievements underscore its dedication to advancing healthcare through reliable and accessible medicines.
DitchCarbon Score
How does Sequent Scientific's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sequent Scientific's score of 24 is lower than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sequent Scientific's reported carbon emissions
In 2024, Sequent Scientific reported total carbon emissions of approximately 20,173,870 kg CO2e for Scope 1 and about 16,394,130 kg CO2e for Scope 2. This reflects their ongoing commitment to transparency in emissions reporting. In 2023, the company recorded Scope 1 emissions of about 17,359,720 kg CO2e and Scope 2 emissions of approximately 13,459,920 kg CO2e, indicating a focus on managing their carbon footprint. Sequent Scientific has set ambitious reduction targets, aiming to decrease Scope 1 emissions by 30% and Scope 2 emissions by 30% by 2030, using a 2021 baseline. This commitment underscores their proactive approach to climate action and aligns with industry standards for sustainability. The company has not disclosed Scope 3 emissions data, which often represents a significant portion of total emissions in many industries. Overall, Sequent Scientific's emissions data and reduction initiatives reflect a strategic commitment to mitigating climate impact and enhancing environmental responsibility.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 7,125,210 | 00,000,000 | 00,000,000 |
| Scope 2 | 16,552,140 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sequent Scientific is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
